PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Anal Gland Neoplasms D000694 1 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Trigeminal Neuralgia D014277 1 associated lipids
Pulmonary Aspergillosis D055732 1 associated lipids
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Zollinger-Ellison Syndrome D015043 1 associated lipids
Angioedemas, Hereditary D054179 2 associated lipids
Epilepsy, Tonic-Clonic D004830 2 associated lipids
Cryptorchidism D003456 2 associated lipids
Decapitation D049248 2 associated lipids
Cystitis, Interstitial D018856 2 associated lipids
Asthma, Aspirin-Induced D055963 2 associated lipids
Optic Neuropathy, Ischemic D018917 2 associated lipids
Choroid Diseases D015862 2 associated lipids
Graves Ophthalmopathy D049970 3 associated lipids
Cryptococcosis D003453 3 associated lipids
Cholangitis D002761 3 associated lipids
Leukemia, B-Cell D015448 3 associated lipids
Dirofilariasis D004184 3 associated lipids
Airway Remodeling D056151 3 associated lipids
HTLV-I Infections D015490 3 associated lipids
Respiratory Sounds D012135 3 associated lipids
Ascariasis D001196 3 associated lipids
Sleep Disorders, Circadian Rhythm D020178 3 associated lipids
Wounds, Stab D014951 3 associated lipids
Headache D006261 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Meningoencephalitis D008590 4 associated lipids
Coronavirus Infections D018352 4 associated lipids
Nasal Obstruction D015508 4 associated lipids
Idiopathic Pulmonary Fibrosis D054990 4 associated lipids
Goiter D006042 4 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Muscular Dystrophy, Animal D009137 5 associated lipids
Tauopathies D024801 6 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Thrombophilia D019851 6 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Sneezing D012912 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Leukemia, Megakaryoblastic, Acute D007947 7 associated lipids
Folliculitis D005499 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Beatty CH et al. Metabolism of arachidonic acid by macaque platelets. Implications for studies on atherosclerosis. 1985 Atherosclerosis pmid:3924062
Mendieta CF et al. Biosynthesis of prostaglandins in gingiva of patients with chronic periodontitis. 1985 J. Periodontol. pmid:3919173
Thompson NT and Scrutton MC Intracellular calcium fluxes in human platelets. 1985 Eur. J. Biochem. pmid:3918866
Rajtar G et al. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. 1985 Biochem. Pharmacol. pmid:3918536
Korbut R and Gryglewski RJ Anti-aggregatory prostanoids. Part I. 1985 Sep-Dec Acta Physiol Pol pmid:3915631
Regulatory control and standardization of allergenic extracts. Clinical studies with "standardized" extracts. 1985 Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M pmid:3901924
Siegl PK and Wenger HC Cardiovascular responses to an isosterically modified prostaglandin analog in the anesthetized dog. 1985 Eur. J. Pharmacol. pmid:3899681
Cutler LS et al. Cytochemical localization of adenylate cyclase in the dense tubule system of human blood platelets stimulated by forskolin, prostacyclin and prostaglandin D2. 1985 Biochim. Biophys. Acta pmid:3890960
Wong P et al. Diminished sensitivity of platelet aggregation to prostaglandin D2 in patients with myeloproliferative disorders and in patients with acute leukemia. 1985 Nippon Ketsueki Gakkai Zasshi pmid:3890456
Fitscha P et al. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease. 1985 Am. J. Hematol. pmid:3885723
Hall TJ et al. Decreased natural killer cell activity in atopic eczema. 1985 Immunology pmid:3876984
Murray JJ et al. Prostaglandin D2 is released during acute allergic bronchospasm in man. 1985 Trans. Assoc. Am. Physicians pmid:3870298
Okuyama S and Mishina H Principia of cancer therapy. XI. Prostaglandin D2 induces redifferentiation of M1 leukemia cells in vitro irrespective of bestatin. 1985 Sci Rep Res Inst Tohoku Univ Med pmid:3870143
Okuyama S and Mishina H Principia of cancer therapy. X. Prostaglandin D2 triggers redifferentiation of the bestatin-treated breast cancer cells in vitro. 1985 Sci Rep Res Inst Tohoku Univ Med pmid:3870142
Okuyama S et al. Redifferentiation of cancer cells: bestatin, estradiol, and prostaglandin D2. 1985 Ann. N. Y. Acad. Sci. pmid:3868328
Gay SW and Kosher RA Prostaglandin synthesis during the course of limb cartilage differentiation in vitro. 1985 J Embryol Exp Morphol pmid:3867724
Walenga RW et al. Re-examination of the assay for plasma prostanoids by solid-phase extraction, and radioimmunoassay. 1985 Prostaglandins Leukot Med pmid:3865240
Bhattacharya SK et al. Prostaglandin D2 mediated specific increase in rat brain serotonin. 1985 Proc. West. Pharmacol. Soc. pmid:3865228
Roberts LJ and Sweetman BJ Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis. 1985 Prostaglandins pmid:3864190
Pugliese G et al. Hepatic transformation of prostaglandin D2 to a new prostanoid, 9 alpha,11 beta-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels. 1985 J. Biol. Chem. pmid:3863819
Liston TE and Roberts LJ Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. 1985 J. Biol. Chem. pmid:3863815
Tanaka H et al. The effects of PGD2 and 9-deoxy-delta 9-PGD2 on colony formation of murine osteosarcoma cells. 1985 Prostaglandins pmid:3863195
Costall B et al. Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent. 1985 Br. J. Pharmacol. pmid:3862460
Liston TE and Roberts LJ Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. 1985 Proc. Natl. Acad. Sci. U.S.A. pmid:3862115
Nielsen JA and Sparber SB Central administration of prostaglandin E2 facilitates while F2 alpha attenuates acute dependence upon morphine rats. 1985 Pharmacol. Biochem. Behav. pmid:3860881
Spannhake EW et al. Influence of mediators of anaphylaxis on collateral ventilation and the lung periphery of the dog. 1985 J. Pharmacol. Exp. Ther. pmid:3860642
Weinreb RN et al. Prostanoids in rabbit aqueous humor: effect of laser photocoagulation of the iris. 1985 Invest. Ophthalmol. Vis. Sci. pmid:3860488
Arisawa M et al. Suppressive effect of prostaglandin D2 on prolactin secretion from rat anterior pituitary. 1985 Asia Oceania J Obstet Gynaecol pmid:3860198
Ikai K et al. Effect of ultraviolet irradiation on mast cell-deficient W/Wv mice. 1985 J. Invest. Dermatol. pmid:3859552
Seregi A et al. The formation and regional distribution of prostaglandins D2 and F2 alpha in the brain of spontaneously convulsing gerbils. 1985 Brain Res. pmid:3859353
Gause GE et al. Hemodynamic effects of postpulmonary administration of prostaglandin D2 in fetal animals. 1985 Proc. Soc. Exp. Biol. Med. pmid:3858885
Watanabe K et al. Enzymatic formation of prostaglandin F2 alpha from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung. 1985 J. Biol. Chem. pmid:3858278
Abbate R et al. Decreased number of PGD2 binding sites on platelets from patients with type IIa hyperlipoproteinemia. 1985 Atherosclerosis pmid:3857047
Narumiya S and Fukushima M delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition. 1985 Biochem. Biophys. Res. Commun. pmid:3857041
Kasukabe T et al. Specific inhibition by prostaglandin D2 and its metabolites of lysozyme synthesis in mouse macrophage-like cell line, Mm-1. 1985 Biochim. Biophys. Acta pmid:3855662
Cooper B Diminished platelet adenylate cyclase activation by prostaglandin D2 in acute thrombosis. 1979 Blood pmid:380688
Narumiya S et al. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei. 1986 J. Pharmacol. Exp. Ther. pmid:3772805
Narumiya S and Fukushima M Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. 1986 J. Pharmacol. Exp. Ther. pmid:3772804
Kato T et al. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo. 1986 Cancer Res. pmid:3708585
Bregman MD et al. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues. 1986 Cancer Res. pmid:3698005
Matsuura H and Imaya H [Effect of prostaglandin (delta 12-PGJ2) on host immunity--an experimental study]. 1987 Gan To Kagaku Ryoho pmid:3592721
Kinoshita T et al. Predominance of prostaglandin D2 and I2 in the rat gastric mucosa--analysis by high-performance liquid chromatography. 1987 Biochem. Int. pmid:3555501
Rao PS et al. Dose-dependent effects of prostaglandin D2 on hemodynamics, renal function, and blood gas analyses. 1987 Am. J. Obstet. Gynecol. pmid:3555078
Holgate ST et al. Primary and secondary effector cells in the pathogenesis of bronchial asthma. 1987 Int. Arch. Allergy Appl. Immunol. pmid:3553030
Strobl-Jäger E et al. Influence of type IIa, IIb and IV-hyperlipoproteinemia on platelet prostaglandin sensitivity, plasma thromboxane B2 and platelet half-life. 1986 Prostaglandins Leukot Med pmid:3540998
Hiroshima O et al. Basal level of prostaglandin D2 in rat brain by a solid-phase enzyme immunoassay. 1986 Prostaglandins pmid:3532208
Huddleston KW et al. Influence of prostaglandin D2 on hemodynamic effects of group B streptococcus in neonatal lambs. 1986 Dev Pharmacol Ther pmid:3530674
Nordlund JJ et al. Prostaglandin E2 and D2 but not MSH stimulate the proliferation of pigment cells in the pinnal epidermis of the DBA/2 mouse. 1986 J. Invest. Dermatol. pmid:3528310
Barnea A et al. Evidence that a short-lived effect of copper leads to amplification of prostaglandin E2 stimulation of the release of gonadotropin-releasing hormone from median eminence explants. 1986 Endocrinology pmid:3525128
Honn KV et al. Possible strategies for antimetastastic therapy. 1986 Prog. Clin. Biol. Res. pmid:3520578